The Globe and Mail

Sofwave Medical Pioneers Non-Invasive Treatment for Arm Reduction and Improved Skin Elasticity With Its Revolutionary SUPERB Technology

Sofwave is setting new standards in arm skin tightening with its safe and effective FDA-cleared non-invasive solution. Following the recently gained FDA clearance, Sofwave Medical is proud to announce ...
Nature

C-Arm for accurate reduction of zygomatic arch fracture — A case report

Discusses complications of an inadequately or unreduced zygomatic arch fracture. Considers various methods used for assessment of the reduction of zygomatic arch fractures intraoperatively. Describes ...
Business Wire

FDA Clears Erchonia’s Zerona Laser for the Non-Invasive Reduction of the Arms

MCKINNEY, Texas--(BUSINESS WIRE)--Erchonia today announces the U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance to market Erchonia’s Zerona body-contouring laser treatment for the ...
PopSugar

What to Know Before Getting a Brachioplasty (aka an Arm Lift)

As information regarding plastic surgery becomes more readily available — through celebrities opening up about it and others posting their experiences on social media — people are discovering new ...
MarketWatch

(PMZN) Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01

The MarketWatch News Department was not involved in the creation of this content. STAFFORD, Texas, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a ...
EDN

ARM-based MCU builds on sub-threshold technology for 10-fold power reduction

This product is featured in EDN's Hot 100 products of 2015. See all 100 here. Ambiq Micro says its Apollo MCUs redefine 'low power' with up to 10x reduction in energy consumption: the ARM ...

Greenwich LifeSciences, Inc.: Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...